Insulet Corporation (PODD) Presents At Baird Global Healthcare Conference 2025 Transcript

Company Overview - Insulet Corporation is a leader in the $4.7 billion global insulin pump market [1] - In 2024, Insulet delivered more than $2 billion in revenue [4] - The company serves over 0.5 million customers globally, with more than 350,000 using its flagship product, Omnipod 5 [4] Product and Market Position - Insulet's Omnipod 5 is the first automated insulin delivery system cleared for both type 1 and type 2 diabetes in the U.S. [4] - The company operates in 25 markets worldwide, driving penetration and market growth [4]